30 Aug Tetra Alzheimer’s Clinical Trials…Ongoing
About this study:
If you or your loved one has early stage Alzheimer’s Disease (AD), you may be eligible for this study. This study is evaluating an investigational drug called BPN14770 as a possible treatment for patients with early stage AD.
You or your loved one may already be taking a cholinesterase inhibitor such as Aricept® (donepezil), but there is a need to find drugs that may work in other ways.
Pharmaceutical companies use clinical studies like this one to learn more about investigational drugs before they are available to the public. Study volunteers can help us in this important research. Thank you for considering participation in this Tetra Alzheimer’s clinical trial.
What is the purpose of this study?
The purpose of this research study is to test an investigational drug called BPN14770. An investigational drug is one that is not yet approved for sale by the United States Food and Drug Administration (FDA).
This study will:
- Test the safety and effectiveness of the study drug BPN14770.
- Test whether it will improve the symptoms of Alzheimer’s Disease.
- Collect data on the drug levels in the blood and the biochemical changes (biomarkers) associated with Alzheimer’s Disease.
How long will the study last?
If you are eligible to enroll in the study, your participation will last approximately 3 to 4 months (14 – 18 weeks, depending on the time between your screening and baseline visit) and will include approximately 8 study visits to the study center.
Who can participate in this study?
To be eligible for this study, you must be:
- 55 to 85 years of age
- Diagnosed with early stage AD
- Receiving Aricept® (donepezil) or another cholinesterase inhibitor for treatment of AD for at least 2 months
- Willing to sign an Informed Consent Form
- Supported by a caregiver who is willing and able to ensure the patient takes their study medications, attends clinic visits, and follows study procedures as instructed
What are my costs to take part in this trial?
All tests and procedures that are part of the study and study visits are provided at no charge to you or your insurance company.
How can I get started?
Step 1: Contact our study coordinator, and he/she will give you information and help determine if you qualify.
Step 2: Give informed consent. A study doctor will explain the procedures and possible benefits and risks. The study doctor will also answer any questions you might have. To join our study, you must read and sign an Informed Consent document to show that you understand the study and what is required of you.
Step 3: Find out if you are eligible. The study staff will ask some health questions and may do a medical evaluation to see if you meet the requirements.